Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

The Israeli Experience in the Control of Poliomyelitis during a Quarter of a Century, 1957-1982

Natan Goldblum and Tiberio Swartz
Reviews of Infectious Diseases
Vol. 6, Supplement 2. International Symposium on Poliomyelitis Control (May - Jun., 1984), pp. S313-S317
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4453360
Page Count: 5
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
The Israeli Experience in the Control of Poliomyelitis during a Quarter of a Century, 1957-1982
Preview not available

Abstract

Data are presented on the programs and the results of immunization against paralytic poliomyelitis in Israel during the 25-year period 1957-1982. To control severe outbreaks of the disease, Israel introduced Salk-type inactivated poliovirus vaccine (IPV) on a large scale in 1957 and used it for a period of five years. Vaccination with IPV had a beneficial effect, demonstrably reducing the morbidity from poliomyelitis. In 1961, Sabin's oral poliovirus vaccine (OPV) was first used during an epidemic outbreak of the disease and has been in continuous use since. Vaccination with OPV has resulted in a highly significant decrease in the incidence of the disease, although sporadic cases continued to occur. This program was supplemented for the past four years with an annual mass vaccination campaign in "high-risk" areas of the country. These additional preventive measures have resulted in a further reduction in morbidity but not in the complete disappearance of the disease.

Page Thumbnails

  • Thumbnail: Page 
S313
    S313
  • Thumbnail: Page 
S314
    S314
  • Thumbnail: Page 
S315
    S315
  • Thumbnail: Page 
S316
    S316
  • Thumbnail: Page 
S317
    S317